AbbVie corporate signage displayed on an office building exterior

PARTNERSHIPS

20 Aug 2025

AbbVie Capstan Pact Powers In-Body Cell Push

AbbVie’s Capstan acquisition boosts interest in in body cell therapies while platforms remain unproven in the clinic

Gene therapy researcher analysing viral vector production data in a laboratory

TECHNOLOGY

29 Jul 2025

Small Digital Steps, Big Hopes for Gene Therapy Manufacturing

Gene therapy producers test data tools and intensified processes to improve viral vector quality and scale

FDA headquarters sign reflecting evolving US gene therapy regulation

REGULATORY

19 Jul 2025

How a Setback Could Shape the Next Era of Gene Therapy

FDA reverses a key vector designation, pushing developers toward tighter data and safer strategies

3D illustration of viral vectors used in gene therapy delivery and manufacturing

INSIGHTS

28 Jun 2025

Inside the US Push to Power the Next Gene Therapy Wave

US groups boost viral vector capacity as demand climbs, raising hopes for steadier gene therapy development

Technicians operating bioreactors during AAV viral vector manufacturing in a cleanroom facility

RESEARCH

16 May 2025

The Race to Reinvent AAV Manufacturing Gains New Fuel

VintaBio’s high yield AAV data points to faster, scalable manufacturing, giving early adopters a potential edge as demand accelerates

SUBSCRIBE FOR UPDATES

By submitting, you agree to receive email communications from the event organizers, including upcoming promotions and discounted tickets, news, and access to related events.